Developing a home device to measure blood metabolites for metabolic disorders
Official title: Whole Blood Point of Care Metabolic Measurement - SB1
Funded at Sequitur Health Corp. · NIH-11008473 · Data updated 2026-11-12
This study is working on a handy device that lets people with certain metabolic disorders check important substances in their blood right at home, making it easier to catch problems early and stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sequitur Health Corp. NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,000,000 |
| NIH project number | 1SB1HD116629-01 |
| Project ID | NIH-11008473 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults with metabolic disorders that require regular monitoring of specific blood metabolites.
✕Less likely to help
Patients who do not have metabolic disorders or those who are not at risk for metabolic crises may not benefit from this research.
What this research studies
This research focuses on creating a home-based device that allows individuals with certain metabolic disorders to monitor specific metabolites in their blood. Currently, these metabolites can only be measured in clinical laboratories, which limits timely intervention during metabolic crises. The project aims to enhance patient care by enabling accurate measurements from a single drop of blood, thus improving health outcomes. The research involves late-stage development and commercialization efforts to address software, hardware, and regulatory challenges associated with bringing this device to market.
Why it matters
Potential benefit: If successful, this research could provide patients with a convenient and effective way to monitor their metabolic health at home, potentially preventing serious health crises.
How similar studies have gone: Previous research has shown success in developing home monitoring devices for other health conditions, indicating potential for this approach in metabolic disorders.
Where this research is happening
-
Sequitur Health Corp.
Scottsdale, United States Active
Researchers
- Principal investigator: Thomas, Marylaura Lind — Sequitur Health Corp.
- Study coordinator: Thomas, Marylaura Lind
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.